Derivatives of pyridoxine for inhibiting HIV integrase
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 9, 2012
Grant Date -
Jul 28, 2011
app pub date -
Jan 11, 2011
filing date -
Jan 22, 2010
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention relates to compounds of Formula I or pharmaceutically acceptable salts, solvates or formulations thereof. Compounds of Formula I inhibit HIV-integrase enzyme and are useful for preventing and treating of HIV infection, acquired immune deficiency syndrome (AIDS), AIDS-related complex (ARC), hepatitis C, and other diseases and conditions caused or mediated by HIV infection.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully